Ronald D. Hart

1.7k total citations
9 papers, 858 citations indexed

About

Ronald D. Hart is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Ronald D. Hart has authored 9 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Ronald D. Hart's work include Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Ronald D. Hart is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Ronald D. Hart collaborates with scholars based in United States. Ronald D. Hart's co-authors include Carolyn Ferree, John Ellerton, W. C. Wood, Anne Moore, Larry Norton, James F. Holland, Marjorie Perloff, Eric P. Winer, Aparna Keshaviah and Rebecca Gelman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

Ronald D. Hart

9 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronald D. Hart United States	9	647	332	150	119	94	9	858
R.D. Gelber Switzerland	18	550 0.9×	403 1.2×	147 1.0×	70 0.6×	101 1.1×	31	1.0k
Rita Lionetto Italy	20	962 1.5×	295 0.9×	320 2.1×	114 1.0×	228 2.4×	53	1.4k
William Hyman United States	11	766 1.2×	483 1.5×	179 1.2×	41 0.3×	155 1.6×	21	1.0k
Philippe Montcuquet France	16	581 0.9×	248 0.7×	332 2.2×	71 0.6×	69 0.7×	38	919
R. Sridhara United States	15	375 0.6×	179 0.5×	234 1.6×	87 0.7×	162 1.7×	24	862
Clarence B. Vaughn United States	15	349 0.5×	236 0.7×	128 0.9×	59 0.5×	100 1.1×	39	669
Sandra J. Ginsberg United States	18	531 0.8×	109 0.3×	316 2.1×	82 0.7×	94 1.0×	38	931
C.J. Twelves United Kingdom	21	746 1.2×	219 0.7×	264 1.8×	22 0.2×	83 0.9×	55	987
Ravi Patel United States	17	798 1.2×	243 0.7×	281 1.9×	309 2.6×	73 0.8×	46	1.3k
Verena Hug United States	16	767 1.2×	688 2.1×	186 1.2×	132 1.1×	345 3.7×	44	1.4k

Countries citing papers authored by Ronald D. Hart

Since Specialization

Citations

This map shows the geographic impact of Ronald D. Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald D. Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald D. Hart more than expected).

Fields of papers citing papers by Ronald D. Hart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald D. Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald D. Hart. The network helps show where Ronald D. Hart may publish in the future.

Co-authorship network of co-authors of Ronald D. Hart

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald D. Hart. A scholar is included among the top collaborators of Ronald D. Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald D. Hart. Ronald D. Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Burstein, Harold J., Aparna Keshaviah, Ari David Baron, et al.. (2007). Trastuzumab plus vinorelbine or taxane chemotherapy for HER2‐overexpressing metastatic breast cancer: The trastuzumab and vinorelbine or taxane study. Cancer. 110(5). 965–972. 152 indexed citations

Burstein, HJ, Aparna Keshaviah, Ronald D. Hart, et al.. (2006). Trastuzumab and vinorelbine or taxane chemotherapy for HER2+ metastatic breast cancer: The TRAVIOTA study. Journal of Clinical Oncology. 24(18_suppl). 650–650. 9 indexed citations

Wood, W. C., Ronald D. Hart, Anne Moore, et al.. (1994). Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma. New England Journal of Medicine. 330(18). 1253–1259. 455 indexed citations

Platanias, Leonidas C., Carole B. Miller, Ronald D. Hart, et al.. (1991). Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients.. Journal of Clinical Oncology. 9(11). 2021–2026. 91 indexed citations

Bruckner, Howard W., et al.. (1988). Leucovorin and 5-fluorouracil as a treatment for disseminated cancer of the pancreas and unknown primary tumors.. PubMed. 48(19). 5570–2. 26 indexed citations

Chahinian, A. Philippe, et al.. (1984). Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma.. PubMed. 44(4). 1688–92. 45 indexed citations

Hart, Ronald D., Marjorie Perloff, & James F. Holland. (1981). One-day vath (vinblastine, adriamycin, thiotepa, and halotestin) therapy for advanced breast cancer refractory to chemotherapy. Cancer. 48(7). 1522–1527. 42 indexed citations

Roboz, John, et al.. (1980). Determination of Methylglyoxal-bis(Guanylhydrazone) in Body Fluids by Ion-Pair Chromatography. Journal of Analytical Toxicology. 4(3). 127–131. 10 indexed citations

Perloff, Marjorie, Ronald D. Hart, & James F. Holland. (1978). Vinblastine, adriamycin, thiotepa, and halotestin (VATH). Therapy for advanced breast cancer refractory to prior chemotherapy. Cancer. 42(6). 2534–2537. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact